•  2013, July 14th: Oral presentation (MDR-1 and ABCG2 inhibitor, elacridar, enhances cytotoxic effects of sunitinib on RCC cell line) #B-9 at 128th Japanese Pharmacological Society Kanto Division, Waseda University, Tokyo, Japan.

(1) Sana Siddig, hiromi Sato, Miaki Uzu, Rina Suzuki, Sayumi Suzuki, Yuki Nomura, Koichi Ueno.

•  2013, April 7th: Master thesis was presented at American Assosiation for Cancer Research. By: Sato Hiromi. Washington, DC, USA. Abstract 983.

(1) Hiromi Sato, Sana Siddig, Rina Suzuki, Miiaki Uzu, Sayumi Suzuki, Yuki Nomura,
Yuko Sekine, Tomoya Uehara, Yasushi Arano. Chiba University, Chiba, Japan.

•  2013, March 21st: Oral presentation (MDR-1 and ABCG2 inhibitor, elacridar, enhances cytotoxic effects of sunitinib on RCC cell line) #AO1F-7-4 at 86th The Japanese Pharmacological Socity, fukuoka city, Japan.

(1)Sana Siddig, hiromi Sato, Rina Suzuki, Miaki Uzu, Sayumi Suzuki, Yuki Nomura, Koichi Ueno.

•  2012, February 5th: poster presentation (literature research of sex-related differences in pharmacokinetics and pharmacodynamics of antihypertensive drugs) #A No.8 at 5th Japanese Association for Gender Specific Medicine Conference , Tokyo Jyoshi Ika University, Tokyo, Japan .

(1)Sana Siddig, Hiromi Sato, Asami Funaki, Momoko Ishikawa, Tomomi Sato, Miaki Uzu, Guligena Tuerdi, Koichi Ueno.

•  2011, February: Attended The annual International Conference of ( Postgraduate Studies and Scientific Research), Khartoum, Sudan .

•  2010, February: Attended the 6 th International Conference ( Pharmaceutical Care ) , University of Medical Sciences and Technology, Khartoum – Sudan .

•  2010, July: Attended (Management of Minor Illness) Course at Blue Nile Training Center, Khartoum, Sudan.

•  2005: Attended the 25 th Scientific Conference of the Arab Pharmacists Union, Khartoum, Sudan.

•  2009: Pharmacy Intership (3 monthes program) Bahri Hospital, Community Pharmacy, Khartoum, Sudan.

•  Computer Skills: PC; Windows; Microsoft Word, Excel, Internet Explorer, PowerPoint.